Filing Overview
Company: QuidelOrtho Corporation
Form and date: Form 8-K filed December 5, 2022, reporting an Item 8.01 “Other Events” matter.
The filing establishes deadlines for stockholder proposals and director nominations for QuidelOrtho’s 2023 Annual Meeting of Stockholders. QuidelOrtho became the successor registrant to Quidel following the business combination with Ortho Clinical Diagnostics Holdings plc.
Financial and Operating Metrics
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, guidance, or other financial performance metrics.
Material Changes Versus Prior Period
No financial or operating changes versus a prior comparable period are reported. The material update is procedural and relates to the 2023 Annual Meeting.
Stockholder Proposal and Nomination Deadlines
- Rule 14a-8 proposals: Proposals intended for inclusion in the proxy statement must be received by the Secretary by 6:00 p.m. Pacific Time on December 12, 2022.
- Director nominations and other business outside Rule 14a-8: Notices must be received no earlier than January 16, 2023 and no later than 6:00 p.m. Pacific Time on February 15, 2023.
- Submissions must comply with applicable laws, SEC rules, and QuidelOrtho’s Amended and Restated Bylaws. Noncompliant proposals may be excluded.
Key Investor Verification Items
- Verify that any stockholder proposal or nomination meets the applicable Rule 14a-8 requirements and the company’s bylaws.
- Confirm receipt of submissions by the Secretary at QuidelOrtho’s principal executive office: 9975 Summers Ridge Road, San Diego, California 92121.
- Review the company’s proxy statement and subsequent filings for the finalized 2023 Annual Meeting date, agenda, and director slate.
- Consult other SEC filings for financial results, liquidity, debt, guidance, and business risks, which are not addressed in this 8-K.